⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6371601 | 1.00 | — | — | |
| SCHEMBL10745821 | 1.00 | — | — | |
| SCHEMBL5491548 | 0.71 | — | — | |
| SCHEMBL7292397 | 0.68 | — | — | |
| SCHEMBL10763563 | 0.68 | — | — | |
| SCHEMBL9777662 | 0.68 | — | — | |
| SCHEMBL11037243 | 0.67 | — | — | |
| SCHEMBL191190 | 0.66 | — | — | |
| SCHEMBL9823784 | 0.61 | — | — | |
| SCHEMBL9823953 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030212085-A1 | Treatment of fibromyalgia and chronic fatigue syndrome | PHARMACIA & UPJOHN COMPANY | 2003-11-13 | — | — | US | disclosed |
| EP-1280530-A1 | TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME | PHARMACIA & UPJOHN COMPANY (US) | 2003-02-05 | — | — | EP | disclosed |
| WO-2002083141-A1 | TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME | PHARMACIA & UPJOHN COMPANY (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2001087308-A1 | TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME | PHARMACIA & UPJOHN COMPANY (US) | 2001-11-22 | — | — | WO | disclosed |